Detalles de la búsqueda
1.
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.
Invest New Drugs
; 42(1): 136-144, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300341
2.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594880
3.
Effectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer: real-world evidence in Japan.
Future Oncol
; 19(37): 2453-2463, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605861
4.
Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
Acta Med Okayama
; 77(3): 301-309, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357631
5.
Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study.
Cancer Sci
; 112(8): 3255-3265, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036692
6.
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Br J Cancer
; 124(2): 383-390, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012782
7.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
N Engl J Med
; 378(24): 2288-2301, 2018 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863955
8.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29151359
9.
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Invest New Drugs
; 39(1): 202-209, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803700
10.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115855
11.
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
Jpn J Clin Oncol
; 51(1): 106-113, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020837
12.
[Malignant Pleural Mesothelioma with High Serum Granulocyte Coronary Stimulating Factor].
Kyobu Geka
; 74(5): 347-351, 2021 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-33980793
13.
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Cancer Sci
; 111(5): 1724-1738, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32159882
14.
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study.
Cancer Sci
; 111(10): 3726-3738, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681682
15.
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.
Jpn J Clin Oncol
; 49(1): 29-36, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30508196
16.
Therapeutic Outcomes of 15 Postoperative Bronchopleural Fistulas Including Seven Endoscopic Interventions.
Acta Med Okayama
; 73(4): 325-331, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31439955
17.
Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.
Cancer Sci
; 109(4): 1177-1184, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29363250
18.
A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 36(4): 667-673, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572782
19.
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
Cancer Sci
; 108(5): 1000-1006, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266091
20.
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
Invest New Drugs
; 35(2): 217-226, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28138828